Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P V Halushka

Showing results (131-140 of 229) with videos related to

Pageof 23
Sort By:
Circulatory Shock|January 1, 1981
Sensitization of essential fatty acid-deficient rats to endotoxin by arachidonate pretreatment: role of thromboxane A2J A Cook, W C Wise, D R Knapp, et al.
The American Journal of Physiology|September 1, 1994
Testosterone increases thromboxane A2 receptor density and responsiveness in rat aortas and plateletsK Matsuda, A Ruff, T A Morinelli, et al.
Progress in Clinical and Biological Research|January 1, 1995
Reorientation of macrophage mediator production in endotoxin toleranceB Zingarelli, H Chen, A P Caputi, et al.
British Journal of Clinical Pharmacology|March 22, 2001
Disposition and metabolism of the flavonoid chrysin in normal volunteersT Walle, Y Otake, J A Brubaker, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1979
13-Azaprostanoic acid: a specific antagonist of the human blood platelet thromboxane/endoperoxide receptorG C Le Breton, D L Venton, S E Enke, et al.
Annals of Internal Medicine|September 1, 1977
Bartter's syndrome: urinary prostaglandin E-like material and kallikrein; indomethacin effectsP V Halushka, H Wohltmann, P J Privitera, et al.
The Journal of Thoracic and Cardiovascular Surgery|May 1, 1989
Treatment of pulmonary vasospasm with prazosin after atrial septal defect closure in a childK Powers, D A Fyfe, A B Taylor, et al.
Advances in Prostaglandin, Thromboxane, and Leukotriene Research|January 1, 1995
Androgen regulation of thromboxane A2 receptorsA A Ajayi, K Matsuda, K Schrör, et al.
Lancet (London, England)|July 24, 1982
Plasma thromboxane concentrations are raised in patients dying with septic shockH D Reines, P V Halushka, J A Cook, et al.
European Journal of Pharmacology|June 25, 1991
Effect of the LTD4 receptor antagonist LY203647 on endotoxic shock sequelae in the ratE J Li, J A Cook, S Ashton, et al.
Pageof 23

Showing results (131-140 of 229) with videos related to

Sort By:
Pageof 23
Circulatory Shock|January 1, 1981
Sensitization of essential fatty acid-deficient rats to endotoxin by arachidonate pretreatment: role of thromboxane A2J A Cook, W C Wise, D R Knapp, et al.
The American Journal of Physiology|September 1, 1994
Testosterone increases thromboxane A2 receptor density and responsiveness in rat aortas and plateletsK Matsuda, A Ruff, T A Morinelli, et al.
Progress in Clinical and Biological Research|January 1, 1995
Reorientation of macrophage mediator production in endotoxin toleranceB Zingarelli, H Chen, A P Caputi, et al.
British Journal of Clinical Pharmacology|March 22, 2001
Disposition and metabolism of the flavonoid chrysin in normal volunteersT Walle, Y Otake, J A Brubaker, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1979
13-Azaprostanoic acid: a specific antagonist of the human blood platelet thromboxane/endoperoxide receptorG C Le Breton, D L Venton, S E Enke, et al.
Annals of Internal Medicine|September 1, 1977
Bartter's syndrome: urinary prostaglandin E-like material and kallikrein; indomethacin effectsP V Halushka, H Wohltmann, P J Privitera, et al.
The Journal of Thoracic and Cardiovascular Surgery|May 1, 1989
Treatment of pulmonary vasospasm with prazosin after atrial septal defect closure in a childK Powers, D A Fyfe, A B Taylor, et al.
Advances in Prostaglandin, Thromboxane, and Leukotriene Research|January 1, 1995
Androgen regulation of thromboxane A2 receptorsA A Ajayi, K Matsuda, K Schrör, et al.
Lancet (London, England)|July 24, 1982
Plasma thromboxane concentrations are raised in patients dying with septic shockH D Reines, P V Halushka, J A Cook, et al.
European Journal of Pharmacology|June 25, 1991
Effect of the LTD4 receptor antagonist LY203647 on endotoxic shock sequelae in the ratE J Li, J A Cook, S Ashton, et al.
Pageof 23